| Literature DB >> 35309654 |
M Selva Meena1, S Priya2, R Thirukumaran1, M Gowrilakshmi3, K Essakiraja3, M S Madhumitha3.
Abstract
Introduction: COVID is a new disease; understanding the transmission dynamics and epidemiological characteristics may help in developing the effective control measures. The study is done 1. To determine the various factors influencing the acquisition of COVID-19 infection among high-risk contacts 2. To estimate the secondary attack rate among high-risk contacts 3. To determine the factors in COVID index cases influencing their secondary attack rate. Methodology: Unmatched case control study was conducted from March to August 2020 among 139 COVID index cases in Madurai district from March-May (Reference period) and their 50 COVID positive (cases), 551 COVID negative (controls) high-risk contacts. Case investigation form* and contact tracing Proforma*were used to collect data. Chi-square test and independent sample t test were used to find out the association. Univariate* and Multivariate logistic regression* were used to predict the risk of various factors in acquisition of COVID infection with the help of adjusted and unadjusted odds ratio. P value < 0.05 was considered statistically significant.Entities:
Keywords: According to our study findings; Case investigation form; contact tracing proforma; multivariate logistic regression; reproductive number; secondary attack rate; univariate logistic regression; • Factors related to acquisition of COVID infection among high-risk contacts are presence of Overcrowding, increase in duration of exposure and Symptomatic status of Index cases.; • Knowledge on these risk factors may throw light in controlling future pandemic diseases following similar mode of transmission.; • Mass screening of the community for the symptoms like fever, cough, sore throat, running nose, and breathlessness at the primary level help in early diagnosis and isolation of affected individuals.; • Preventive measures like social distancing must be emphasized in the community as well as in the households having symptomatic family member.
Year: 2022 PMID: 35309654 PMCID: PMC8930103 DOI: 10.4103/jfmpc.jfmpc_355_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Factors influencing acquisition of COVID-19 between Cases and Controls (n=601)
| Factors | Cases | Controls | Total | Chi-Square | Unadjusted odds ratio (95% Confidence Interval) | |
|---|---|---|---|---|---|---|
| Age | ||||||
| <=14 YRSa | 9 (7.4%) | 112 (92.6%) | 121 (100%) | - | ||
| 15-48 YRS | 32 (8.9%) | 327 (91.1%) | 359 (100%) | 0.814 | 0.616 | 1.218 (0.564-2.630) |
| >48 | 9 (7.4%) | 112 (9`2.6%) | 121 (100%) | 1.000 (0.383-2.613) | ||
| Sex | ||||||
| Male | 33 (11.6%) | 252 (88.4%) | 285 (100%) | 0.006* | 0.007* | 2.303 (1.253-4.233) |
| Femalea | 17 (5.4%) | 299 (94.6%) | 316 (100%) | - | ||
| Overcrowding | ||||||
| Absenta | 5 (2.5%) | 192 (97.5%) | 197 (100%) | - | ||
| Present | 45 (11.1%) | 359 (88.9%) | 404 (100%) | 0.000* | 0.001* | 4.813 (1.879-12.327) |
| Duration of Exposure | ||||||
| 1-3 Daysa | 7 (3.1%) | 222 (96.9%) | 229 (100%) | - | ||
| 4-7 Days | 33 (9.9%) | 300 (90.1%) | 333 (100%) | 0.000* | 0.000* | 3.489 (1.515-8.031) |
| >7 Days | 10 (25.6%) | 29 (74.4%) | 39 (100%) | 0.005* | 10.936 (3.863-30.956) | |
| Hours of Exposure/day | ||||||
| <=6 Hrsa | 16 (5.7%) | 267 (94.3%) | 283 (100%) | - | ||
| 7-12 Hrs | 22 (8%) | 254 (92%) | 276 (100%) | 0.000* | 0.000* | 1.445 (0.742-2.815) |
| >12 Hrs | 12 (28.6%) | 30 (71.4%) | 42 (100%) | 0.000* | 6.675 (2.887-15.435) | |
| Diabetes | ||||||
| Absenta | 43 (7.8%) | 510 (92.2%) | 553 (100%) | - | ||
| Present | 7 (14.6%) | 41 (85.4%) | 48 (100%) | 0.101 | 0.108 | 2.025 (0.857-4.785) |
| Hypertension | ||||||
| Absenta | 49 (8.4%) | 537 (91.6%) | 586 (100%) | 0.814 | 0.815 | - |
| Present | 1 (6.7%) | 14 (93.3%) | 15 (100%) | 0.783 (0.101-6.079) | ||
| Co-morbidity status | ||||||
| Absenta | 43 (7.8%) | 509 (92.2%) | 552 (100%) | 0.115 | 0.121 | - |
| Present | 7 (14.3%) | 42 (85.7%) | 49 (100%) | 1.973 (0.836-4.655) | ||
| Relationship | ||||||
| Spousea | 4 (4.5%) | 85 (95.5%) | 89 (100%) | - | - | |
| Children | 16 (9.8%) | 147 (90.2%) | 163 (100%) | 0.711 | 0.945 | 2.313 (0.749-7.144) |
| Parent | 8 (8.4%) | 87 (91.6%) | 95 (100%) | 0.384 | 1.954 (0.567-6.731) | |
| Friends | 4 (9.1%) | 40 (90.9%) | 44 (100%) | 0.490 | 2.125 (0.506-8.933) | |
| Others | 18 (8.6%) | 192 (91.4%) | 210 (100%) | 0.225 | 1.992 (0.655-6.064) | |
| Type of contact | ||||||
| Householda | 42 (8.1%) | 479 (91.9%) | 521 (100%) | 0.442 | - | - |
| Friends | 4 (9.1%) | 40 (90.9%) | 44 (100%) | 0.811 | 1.140 (0.389-3.342) | |
| Workplace | 4 (15.4%) | 22 (84.6%) | 26 (100%) | 0.198 | 2.074 (0.683-6.299) | |
| Healthcare | 0 (0%) | 10 (100%) | 10 (100%) | 0.999 | 0.000 |
*Statistically significant (P<0.05). aReference category
Adjusted Odds Ratio For Factors Influencing Acquisition Of COVID-19 between Cases And Controls Using Multivariate Logistic Regression (n=601)
| Factors |
| Adjusted odds ratio (95% Confidence Interval) |
|---|---|---|
| Sex | ||
| Femalea | - | - |
| Male | 0.005* | 2.520 (1.321-4.806) |
| Overcrowding | ||
| Absenta | - | - |
| Present | 0.007* | 3.810 (1.434-10.125) |
| Duration of exposure in days | ||
| 1-3 Daysa | - | - |
| 4-7 Days | 0.014* | 2.902 (1.237-6.808) |
| >7 Days | 0.001* | 6.748 (2.282-19.960) |
| Duration of exposure in hours/day | ||
| <=6 Hrsa | - | - |
| 7-12 Hrs | 0.709 | 1.144 (0.566-2.311) |
| >12 Hrs | 0.000* | 5.543 (2.227-13.797) |
*Statistically significant (P<0.05). aReference category
Association of Index case factors with their Secondary Attack Rate (n=139)
| Factors | Frequency (%) | Mean (SAR) | Standard deviation |
|
|
|---|---|---|---|---|---|
| Outcome | |||||
| Death | 2 (1.44%) | 41.428 | 2.020 | ||
| Discharge | 137 (98.56%) | 8.375 | 20.638 | -2.257 | 0.026* |
| Sex | |||||
| Male | 103 (74.11%) | 0.1942 | 0.397 | ||
| Female | 36 (25.89%) | 0.2778 | 0.454 | -1.046 | 0.297 |
| Fever | |||||
| Absent | 118 (84.9%) | 0.1695 | 0.376 | ||
| Present | 21 (15.1%) | 0.4762 | 0.511 | -3.243 | 0.001* |
| Sore throat | |||||
| Absent | 132 (94.97%) | 0.1970 | 0.399 | ||
| Present | 7 (5.03%) | 0.5714 | 0.534 | -2.377 | 0.019* |
| Nausea/Vomiting | |||||
| Absent | 138 (99.29%) | 0.2101 | 0.408 | ||
| Present | 1 (0.71%) | 1.000 | -1.925 | 0.056 | |
| General Weakness | |||||
| Absent | 136 (97.85%) | 0.2132 | 0.411 | ||
| Present | 3 (2.15%) | 0.333 | 0.577 | -0.497 | 0.620 |
| Breathlessness | |||||
| Absent | 130 (93.53%) | 0.1923 | 0.395 | ||
| Present | 9 (6.47%) | 0.5556 | 0.527 | -2.605 | 0.010* |
| Headache | |||||
| Absent | 136 (97.85%) | 0.2059 | 0.405 | ||
| Present | 3 (2.15%) | 0.6667 | 0.577 | -1.931 | 0.056 |
| Cough | |||||
| Absent | 119 (85.65%) | 0.1765 | 0.382 | ||
| Present | 20 (14.38%) | 0.450 | 0.510 | -2.809 | 0.006* |
| Diarrhea | |||||
| Absent | 137 (98.57%) | 0.2117 | 0.410 | ||
| Present | 2 (1.43%) | 0.500 | 0.707 | -0.980 | 0.329 |
| Running nose | |||||
| Absent | 129 (92.81%) | 0.1860 | 0.390 | ||
| Present | 10 (7.19%) | 0.600 | 0.516 | -3.152 | 0.002* |
| Pain | |||||
| Absent | 133 (95.69%) | 0.2030 | 0.403 | ||
| Present | 6 (4.31%) | 0.50 | 0.547 | -1.736 | 0.085 |
| Symptom Status | |||||
| Absent | 106 (76.86%) | 0.1415 | 0.350 | ||
| Present | 33 (23.14%) | 0.4545 | 0.505 | -4.005 | 0.000* |
| Hypertension | |||||
| Absent | 131 (94.25%) | 0.2061 | 0.406 | ||
| Present | 8 (5.75%) | 0.375 | 0.517 | -1.124 | 0.263 |
| Diabetes mellitus | |||||
| Absent | 125 (89.93%) | 0.192 | 0.395 | ||
| Present | 14 (10.07%) | 0.428 | 0.513 | -2.057 | 0.042* |
| Co-morbidity Status | |||||
| Absent | 112 (80.58%) | 0.2054 | 0.405 | ||
| Present | 27 (19.42%) | 0.2593 | 0.446 | -0.608 | 0.545 |
*Statistically significant (P<0.05). SAR - Secondary Attack Rate
Correlation of age and duration of hospital stay of index case with their Secondary Attack Rate (n=139)
| Factors | Pearson’s correlation coefficient “r” |
|
|---|---|---|
| Age | -0.531 | 0.596 |
| Duration of hospital stay | 0.217 | 0.828 |